Why prevention is becoming one of the highest-return public investments for countries facing rising healthcare costs, ageing populations and lifestyle diseases. Healthcare systems become expensive when they intervene too late. Around the world, non-communicable diseases such as cardiovascular disease, diabetes, cancer and chronic respiratory illness now account for 75% of non-pandemic-related deaths. Many of these conditions are preventable or can be delayed through early screening, vaccination, nutrition, tobacco control, community health and healthier urban design. Global evidence is clear: prevention saves lives and reduces future costs. WHO estimates that scaling up proven NCD interventions could save 12 million lives, prevent 28 million heart attacks and strokes, add 150 million healthy life years, and generate over US$1 trillion in economic benefits by 2030. For India, prevention is not only a health priority. It is an economic necessity. India has around 220 million adults with hypertension, only 12% of whom have blood pressure under control. Public health spending has improved, but out-of-pocket expenditure still accounted for 43.4% of total health expenditure in 2022–23. If India wants to become a developed economy by 2047, preventive healthcare must become a core pillar of economic strategy. Why This Matters Most healthcare systems spend heavily after citizens fall ill. Hospitals are built after disease rises. Medicines are purchased after patients are diagnosed. Insurance claims increase after families face health shocks. Prevention reverses this logic. It asks a more strategic question: How can a country reduce the number of people who need expensive treatment in the first […]